Connection

Karine Lacombe to Liver Cirrhosis

Back to Details
This is a "connection" page, showing publications Karine Lacombe has written about Liver Cirrhosis.
Karine Lacombe
Connection Strength
0.617
Liver Cirrhosis
  1. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study. J Int AIDS Soc. 2017 02 28; 20(1):21426.
    View in: PubMed
    Score: 0.288
  2. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1387-1396.
    View in: PubMed
    Score: 0.087
  3. Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients. AIDS. 2017 09 10; 31(14):1955-1964.
    View in: PubMed
    Score: 0.075
  4. Diagnostic accuracy of the Coopscore© to predict liver fibrosis in human immunodeficiency virus/hepatitis B virus co-infection. Ann Clin Biochem. 2018 Mar; 55(2):236-243.
    View in: PubMed
    Score: 0.074
  5. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals. AIDS. 2017 06 01; 31(9):1223-1234.
    View in: PubMed
    Score: 0.073
  6. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. Clin Infect Dis. 2018 09 14; 67(7):1010-1017.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.